Clinical Trials and Epidemiology Research Unit, Singapore.
Value Health. 2009 Mar-Apr;12(2):371-6. doi: 10.1111/j.1524-4733.2008.00448.x. Epub 2008 Sep 9.
OBJECTIVE: This study aims to develop a function for mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General (FACT-G) scores to the EuroQoL Group's EQ-5D utility index and to test whether a single function is sufficient for the two language versions. METHODS: A baseline survey of 558 cancer patients in Singapore using the FACT-G and EQ-5D was conducted (308 English and 250 Chinese questionnaires). Regression models were used to predict the EQ-5D utility index values based on the FACT-G scores and thus derive a mapping equation. Data from a follow-up survey of the patients were used to validate the results. RESULTS: The FACT-G Social/Family scale was not associated with the EQ-5D utility index (P = 0.701). There was no interaction between language version and the predictors (each P > 0.1). An equation that maps the FACT-G Physical, Emotional, and Functional well-being scales to the EQ-5D utility index was derived. In the validation sample, the mean observed utility values was larger than the mapped by only 0.005 (95% confidence interval [CI]-0.006 to 0.016), but the mean absolute difference was 0.083 (95% CI 0.076 to 0.090). CONCLUSIONS: At the group level, but not individual level, the equation developed can accurately map the English and Chinese versions of the FACT-G scores to the EQ-5D utility index.
目的:本研究旨在为英文版和中文版癌症治疗功能评估-一般量表(FACT-G)的分数制定一个映射到欧洲五维健康量表(EQ-5D)效用指数的功能,并检验一个单一的函数是否足以适用于这两种语言版本。
方法:对新加坡的 558 名癌症患者进行了基线调查,使用 FACT-G 和 EQ-5D(308 份英文问卷和 250 份中文问卷)。回归模型用于根据 FACT-G 分数预测 EQ-5D 效用指数值,从而得出映射方程。患者的后续调查数据用于验证结果。
结果:FACT-G 社会/家庭量表与 EQ-5D 效用指数无关(P=0.701)。语言版本和预测因子之间没有交互作用(均 P>0.1)。得出了一个将 FACT-G 身体、情感和功能健康量表映射到 EQ-5D 效用指数的方程。在验证样本中,观察到的平均效用值比映射值仅大 0.005(95%置信区间[CI]为 0.006 至 0.016),但平均绝对差异为 0.083(95%CI 为 0.076 至 0.090)。
结论:在群体水平上,但不是在个体水平上,所开发的方程可以准确地将英文版和中文版 FACT-G 分数映射到 EQ-5D 效用指数。
Value Health. 2012-2-2
Med Decis Making. 2010-4-7
Health Qual Life Outcomes. 2015-7-16
Clin Gastroenterol Hepatol. 2024-1
Breast Cancer. 2021-1
Jpn J Clin Oncol. 2020-6-10
Health Qual Life Outcomes. 2019-10-15
Health Qual Life Outcomes. 2019-5-10